Skip to main content

Market Overview

Intellia Therapeutics, Inc. (NTLA)

70.79 0.00 (0.00%)

Earnings

QuarterPriorEstimateActualSurprise
Q4 2021
Pre-Market
EPS:
REV:




Q3 2021
Pre-Market
EPS:
REV:
-0.47
22.22M



Q2 2021
Pre-Market
EPS:
REV:




Q1 2021
Pre-Market
EPS:
REV:
-0.63
12.916M



Q4 2020
Pre-Market
EPS:
REV:
-0.57
10.936M
-0.60
14.09M
-0.69
6.595M
-15%
-53.19%
Q3 2020
Pre-Market
EPS:
REV:
-0.49
10.616M
-0.59
15.58M
-0.47
22.22M
20.34%
42.62%
Q2 2020
Pre-Market
EPS:
REV:
-0.56
11.118M
-0.69
8.54M
-0.61
16.263M
11.59%
90.43%
Q1 2020
Pre-Market
EPS:
REV:
-0.49
10.433M
-0.44
18.14M
-0.63
12.916M
-43.18%
-28.8%
Q4 2019
Pre-Market
EPS:
REV:
-0.43
7.88M
-0.56
9.94M
-0.57
10.936M
-1.79%
10.02%
Q3 2019
Pre-Market
EPS:
REV:
-0.53
7.408M

-0.49
10.616M

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!